Replies to post #113964 on Biotech Values

[go seek]

RR, could t-enox be not Lupenox per se, but a product from ItalFarmaco that is essentially unchanged from the product ItalFarmaco licensed to Lupin for sale in India as Lupenox?

If not, could you be wrong in your analysis?

I think most would admit it may not be the above ItalFarmaco product, but do you have any evidence it is not?

If it is the above ItalFarmco product would you say the risk / reward favors MNTA longs?


This may be too many questions... in any case Best Wishes.

[HattieTheWitch]

...Would they send out a minor deficiency letter if T-enox was Lupenox? I think they'd outright reject it...

(my emphasis)

I agree, and that's the big problem I have with the proposition that Teva's t-enox submission is Lupenox.

If this point has been addressed, I don't recall it.